The potential for PK DDI between CHP and pola was evaluated using exposure comparisons between patients receiving pola + R/G-CHP and those with R/R DLBCL or FL receiving pola with R/G in a phase II study [17, 35]. This evidence concerns the gene POLA1 and diffuse large B-cell lymphoma.